JAMES HERLIHY to Fetal Blood
This is a "connection" page, showing publications JAMES HERLIHY has written about Fetal Blood.
Connection Strength
0.046
-
Randomized, double-blinded, placebo-controlled trial of allogeneic cord blood T-regulatory cells for treatment of COVID-19 ARDS. Blood Adv. 2023 07 11; 7(13):3075-3079.
Score: 0.046